Health Ingredients Europe Sneak Peek: Staving Off Postprandial Blood Glucose Spikes
Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals.
Wacker offers a soluble dietary fiber that is scientifically proven and acknowledged by EFSA to have a significant effect on reducing postprandial glycaemic response. This fiber, branded under the trademark Cavamax W6, is an alpha-cyclodextrin, a carbohydrate enzymatically derived from starch. Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals. Further clinical trials show a positive effect of Cavamax W6 on blood lipid levels. Cavamax W6 is highly stable in heat and acidic conditions, is non-hygroscopic and non-browning, and is ideally suited for beverage applications.
Booth C46
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
